Skip to main content

Acute and intermittent LHRH agonist dosing as post-coital and anti-ovulatory contraceptive approaches

  • Chapter
Future Aspects in Contraception
  • 69 Accesses

Abstract

Under physiological conditions, LH and FSH are stimulated by LHRH from the hypothalamus and are released from the gonadotrophs in a pulsatile manner. Gonadotrophin pulsation is required for adequate control of ovarian function. It has been well documented that acute and repetitive administrations of potent LHRH agonists have paradoxical antifertility effects. In female animals of several species various treatments cause inhibition of ovulation, induce luteolysis and terminate pregnancy (Balmaceda and Asch, 1981; Corbin and Bex, 1981; Vickery and McRae, 1984). In normal women daily administration of LHRH agonist inhibits ovulation (Nillius et al., 1978; Schmidt-Gollwitzer et al., 1981). Acute and short-term dosing have also been shown to interfere with follicular maturation when administered in the early follicular phase of the menstrual cycle (Sheehan et al., 1982; Skarin et al., 1982a) and with corpus luteum function when administered after ovulation (Koyama et al., 1978; Casper and Yen, 1979; Lemay et al., 1979; Bergquist et al., 1980; Lemay et al., 1982, 1983c).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Balmaceda, J. P. and Asch, R. H. (1981). The effect of LHRH agonistic analogs during the luteal phase of the rhesus monkey. In Zatuchni, G. I., Shelton, J. D. and Sciarra J. J. (eds.) LHRH Peptides as Female and Male Contraceptives, pp. 86–100. ( Philadelphia: Harper and Row )

    Google Scholar 

  • Bergquist, C., Nillius, S. J. and Wide, L. (1980). Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women. Contraception, 22, 287

    Article  PubMed  CAS  Google Scholar 

  • Bergquist, C., Nillius, S. J., Wide, L. and Lindgren, A. (1981). Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception. Fertil. Steril., 36, 339

    PubMed  CAS  Google Scholar 

  • Bergquist, C., Nillius, S. J. and Wide, L. (1982). Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women. Fertil. Steril., 38, 190

    PubMed  CAS  Google Scholar 

  • Casper, R. F. and Yen, S.S.C. (1979). Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor. Science, N. Y., 205, 408

    Article  CAS  Google Scholar 

  • Corbin, A. and Bex, F. J. (1981). Physiology and contraceptive effects of LHRH and agonistic analogs in female animals. In Zatuchni, G. I., Shelton, J. D. and Sciarra, J. J. (eds.) LHRH Peptides as Female and Male Contraceptives, pp. 68–84. ( Philadelphia: Harper and Row )

    Google Scholar 

  • Hardt, W., Schmidt-Gollwitzer, K., Nevinny-Stickel, J. and Schmidt-Gollwitzer, M. (1982). Progress in the contraceptive use of the LH-RH agonist buserelin by intermittent medication with withdrawal bleeding induced by a progestational agent. Geburtsh. Frauenheilk., 41, 874

    Article  Google Scholar 

  • Koyama, T., Ohkura, T., Kumasaka, T. and Saito, M. (1978). Effect of postovulatory treatment with a luteinizing hormone-releasing hormone analog on the plasma level of progesterone in women. Fertil. Steril., 30, 49

    Google Scholar 

  • Lemay, A., Labrie, F., Manger, A. and Raynaud, J. P. (1979). Luteolytic effect of intranasal administration of [D-Ser(TBU)6-des-Gly-NH210]-luteinizing hormone-releasing hormone ethylamide in normal women. Fertil. Steril., 32, 646

    PubMed  CAS  Google Scholar 

  • Lemay, A., Faure, N. and Labrie, F. (1982). Sensitivity of pituitary and corpus luteum responses to single intranasal administration of [D-Ser(TBU)6-des-Gly-NH10] luteinizing hormone-releasing hormone ethylamide (buserelin) in normal women. Fertil. Steril., 37, 193

    PubMed  CAS  Google Scholar 

  • Lemay, A., Faure, N., Labrie, F. and Fazekas, A.T.A. (1983a). Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge. Fertil. Steril., 39, 661

    PubMed  CAS  Google Scholar 

  • Lemay, A., Metha, A. E., Tolis, G., Faure, N., Labrie, F. and Fazekas, A.T.A. (1983b). Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase. Fertil. Steril., 39, 668

    PubMed  CAS  Google Scholar 

  • Lemay, A., Faure, N., Labrie, F. and Fazekas, A.T.A. (1983c). Intranasal LHRH agonist (buserelin) after ovulation: a post-coital contraceptive approach. Contracept. Deliv. Syst., 4, 107

    PubMed  CAS  Google Scholar 

  • Nillius, S. J., Bergquist, C. and Wide, L. (1978). Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue — a new approach to birth control? Contraception, 17, 537

    Article  Google Scholar 

  • Schmidt-Gollwitzer, M., Hardt, W. and Schmidt-Gollwitzer, K. (1981). Influence of the LH¬RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control? Contraception, 23, 187

    Article  PubMed  CAS  Google Scholar 

  • Sheehan, K. L., Casper, R. F. and Yen, S.S.C. (1982). Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor. A model for fertility control. Science, N. Y., 215, 170

    Article  CAS  Google Scholar 

  • Skarin, G., Nillius, S. J. and Wide, L. (1982a). Early follicular phase luteinizing hormone-releasing hormone agonist administration-Effects on follicular maturation and corpus luteum function in women. Contraception, 25, 31

    Article  PubMed  CAS  Google Scholar 

  • Skarin, G., Nillius, S. J. and Wide, L. (1982b). Failure to induce early abortion by huge doses of a superactive LRH agonist in women. Contraception, 26, 457

    Article  PubMed  CAS  Google Scholar 

  • Tolis, G., Comaru-Schally, A. M., Metha, A. E. and Schally, A. V. (1981). Failure to interrupt established pregnancy in humans by D-tryptophan-6-luteinizing hormone-releasing hormone. Fertil. Steril., 36, 241

    PubMed  CAS  Google Scholar 

  • Vickery, B. H. and McRae, G. I. (1984). LHRH agonists for control of female fertility: primate studies. In Vickery, B. H., Nestor, J. J. Jr. and Hafez, E. S. E. (eds.) LHRH and its Analogs: Contraceptive and Therapeutic Applications, pp. 91–106. ( Boston: MTP )

    Google Scholar 

Download references

Authors

Editor information

B. Runnebaum T. Rabe L. Kiesel

Rights and permissions

Reprints and permissions

Copyright information

© 1985 MTP Press Limited

About this chapter

Cite this chapter

Lemay, A., Faure, N., Labrie, F., Fazekas, A.T.A. (1985). Acute and intermittent LHRH agonist dosing as post-coital and anti-ovulatory contraceptive approaches. In: Runnebaum, B., Rabe, T., Kiesel, L. (eds) Future Aspects in Contraception. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4916-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4916-4_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8678-3

  • Online ISBN: 978-94-009-4916-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics